FDA Recall Open, Classified

Tandem Mobi Insulin Pump with Interoperable Technology

Recall: Z-1520-2025 · Initiated February 27, 2025

Recall

Recall Number
Z-1520-2025
Event Number
96417
Firm
Tandem Diabetes Care, Inc.
FEI Number
3007981285
Product Code
QFG
Status
Open, Classified
Root Cause
Software Design Change
Initiated
February 27, 2025
Posted
April 11, 2025
Address
12400 High Bluff Dr, San Diego, CA, 92130-3077

Description

Tandem Mobi Insulin Pump with Interoperable Technology

Reason

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

Action

On February 28, 2025 Tandem Diabetes Care contacted each affected customer by phone concerning a Urgent Medical Device Correction. On March 11, 2025, Tandem followed up with a "Urgent Medical Device" Recall notification via E-Mail to affected consignees. Tandem ask consignees to take the following action: 1. Turn off Control-IQ+ immediately. You may continue to use your pump without Control-IQ active. Your pump will deliver insulin based on your programmed active personal profile and will not automatically adjust insulin delivery. 2. Please refer to the user guide provided with your pump for more detailed instructions. 3. Continue using your Tandem pump as described in the User Guide. 4. Pay attention to all system alerts and alarms. 5. Always carry back-up supplies.

Distribution

US: AZ, CA, CO, CT, FL, HI, IA, ID, IL, IN, MD, ME, MI, MO, MS, NC, ND, NE, NJ, NM, NV, NY, OH, PA, TX, UT, VA, WA, WI OUS: N/A

Quantity

85 units